title: ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
abstract: Colorectal cancer (CRC) is one of the most common malignancies in Western countries. Over the last 20 years, and the last decade in particular, the clinical outcome for patients with metastatic CRC (mCRC) has improved greatly due not only to an increase in the number of patients being referred for and undergoing surgical resection of their localised metastatic disease but also to a more strategic approach to the delivery of systemic therapy and an expansion in the use of ablative techniques. This reflects the increase in the number of patients that are being managed within a multidisciplinary team environment and specialist cancer centres, and the emergence over the same time period not only of improved imaging techniques but also prognostic and predictive molecular markers. Treatment decisions for patients with mCRC must be evidence-based. Thus, these ESMO consensus guidelines have been developed based on the current available evidence to provide a series of evidence-based recommendations to assist in the treatment and management of patients with mCRC in this rapidly evolving treatment setting.
authors.affiliation: Digestive Oncology, University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium clinicalguidelines@esmo.org.
authors.forename: E
authors.initials: E
authors.lastname: Van Cutsem
authors.affiliation: Medical Oncology Department, INCLIVA University of Valencia, Valencia, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Cervantes
authors.affiliation: Hepato-Biliary Centre, Paul Brousse Hospital, Villejuif, France.
authors.forename: R
authors.initials: R
authors.lastname: Adam
authors.affiliation: Medical Oncology, IRCCS San Martino Hospital, Genova, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Sobrero
authors.affiliation: Research Institute for Oncology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
authors.forename: J H
authors.initials: JH
authors.lastname: Van Krieken
authors.affiliation: Division of Oncology, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel.
authors.forename: D
authors.initials: D
authors.lastname: Aderka
authors.affiliation: Medical Oncology Department, University Hospital Reina Sofia, Cordoba, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Aranda Aguilar
authors.affiliation: School of Medicine, University of Turin, Turin, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Bardelli
authors.affiliation: Division of Hematology/Oncology, Northwestern Medical Group, Chicago, USA.
authors.forename: A
authors.initials: A
authors.lastname: Benson
authors.affiliation: Department of Oncology, St László Hospital, Budapest, Hungary.
authors.forename: G
authors.initials: G
authors.lastname: Bodoky
authors.affiliation: Division of Medical Oncology, Seconda Università di Napoli, Naples, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Ciardiello
authors.affiliation: Abdominal Surgery, University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium.
authors.forename: A
authors.initials: A
authors.lastname: D'Hoore
authors.affiliation: Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Diaz-Rubio
authors.affiliation: Medical Oncology, Institut de Cancérologie de l'Ouest (ICO), St Herblain.
authors.forename: J-Y
authors.initials: JY
authors.lastname: Douillard
authors.affiliation: Department of Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
authors.forename: M
authors.initials: M
authors.lastname: Ducreux
authors.affiliation: Department of Medical Oncology, University of Pisa, Pisa, Italy Division of Medical Oncology, Department of Oncology, University Hospital 'S. Chiara', Istituto Toscano Tumori, Pisa, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Falcone
authors.affiliation: Division of Medical Oncology, Mayo Clinic, Rochester, USA.
authors.forename: A
authors.initials: A
authors.lastname: Grothey
authors.affiliation: Department of Surgery I, Rudolfstiftung Hospital, Vienna, Austria.
authors.forename: T
authors.initials: T
authors.lastname: Gruenberger
authors.affiliation: Department of Radiation Oncology, University Hospitals Gasthuisberg and KU Leuven, Leuven, Belgium.
authors.forename: K
authors.initials: K
authors.lastname: Haustermans
authors.affiliation: Comprehensive Cancer Center, University Clinic Munich, Munich, Germany.
authors.forename: V
authors.initials: V
authors.lastname: Heinemann
authors.affiliation: Instituto do Câncer do Estado de São Paulo, University of São Paulo, São Paulo, Brazil.
authors.forename: P
authors.initials: P
authors.lastname: Hoff
authors.affiliation: Northwest German Cancer Center, University Campus Klinikum Oldenburg, Oldenburg, Germany.
authors.forename: C-H
authors.initials: CH
authors.lastname: Köhne
authors.affiliation: Cancer Center, Ospedale Giovanni XXIII, Bergamo, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Labianca
authors.affiliation: Digestive Oncology Department, European Hospital Georges Pompidou, Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Laurent-Puig
authors.affiliation: Department of Clinical Oncology, Prince of Wales Hospital, State Key Laboratory in Oncology in South China, Chinese University of Hong Kong, Shatin, Hong Kong.
authors.forename: B
authors.initials: B
authors.lastname: Ma
authors.affiliation: CRUK/MRC Oxford Institute for Radiation Oncology, Gray Laboratories, University of Oxford, Oxford, UK.
authors.forename: T
authors.initials: T
authors.lastname: Maughan
authors.affiliation: Department of Clinical Oncology and Outpatient Treatment Center, Aichi Cancer Center Hospital, Nagoya, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Muro
authors.affiliation: Cell Biology and Biotherapy Unit, I.N.T. Fondazione G. Pascale, Napoli, Italy.
authors.forename: N
authors.initials: N
authors.lastname: Normanno
authors.affiliation: Helsinki University Central Hospital, Comprehensive Cancer Center, Helsinki, Finland Department of Oncology, University of Helsinki, Helsinki, Finland.
authors.forename: P
authors.initials: P
authors.lastname: Österlund
authors.affiliation: The Institute of Cancer Research and The Royal Marsden Hospital, London, UK.
authors.forename: W J G
authors.initials: WJ
authors.lastname: Oyen
authors.affiliation: Department of Medical Oncology, Bank of Cyprus Oncology Centre, Nicosia, Cyprus.
authors.forename: D
authors.initials: D
authors.lastname: Papamichael
authors.affiliation: Department of Medical Oncology, University of Ioannina, Ioannina, Greece.
authors.forename: G
authors.initials: G
authors.lastname: Pentheroudakis
authors.affiliation: Department of Oncology, Odense University Hospital, Odense, Denmark.
authors.forename: P
authors.initials: P
authors.lastname: Pfeiffer
authors.affiliation: Haematology and Medical Oncology Unit, Queen Elizabeth Hospital, Woodville, Australia.
authors.forename: T J
authors.initials: TJ
authors.lastname: Price
authors.affiliation: Department of Medical Oncology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
authors.forename: C
authors.initials: C
authors.lastname: Punt
authors.affiliation: Department of Radiology and Nuclear Medicine, University Clinic Magdeburg, Magdeburg, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Ricke
authors.affiliation: Digestive Tumors Unit, Geneva University Hospitals (HUG), Geneva, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Roth
authors.affiliation: Catalan Institute of Oncology (ICO), Barcelona, Spain.
authors.forename: R
authors.initials: R
authors.lastname: Salazar
authors.affiliation: Department of Internal Medicine I and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
authors.forename: W
authors.initials: W
authors.lastname: Scheithauer
authors.affiliation: Department of Internal Medicine IV, University Clinic Halle, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
authors.forename: H J
authors.initials: HJ
authors.lastname: Schmoll
authors.affiliation: Medical Oncology Department, Vall d' Hebron University Hospital, Vall d'Hebron Institute of Oncology (V.H.I.O.), Barcelona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Tabernero
authors.affiliation: Digestive Oncology Department, European Hospital Georges Pompidou, Paris, France.
authors.forename: J
authors.initials: J
authors.lastname: Taïeb
authors.affiliation: Digestive Oncology, University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium.
authors.forename: S
authors.initials: S
authors.lastname: Tejpar
authors.affiliation: Department of Cancer Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
authors.forename: H
authors.initials: H
authors.lastname: Wasan
authors.affiliation: Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Yoshino
authors.affiliation: Digestive Oncology Department, European Hospital Georges Pompidou, Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Zaanan
authors.affiliation: Instituto CUF de Oncologia (ICO), Lisbon, Portugal.
authors.forename: D
authors.initials: D
authors.lastname: Arnold
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D017408:Guidelines as Topic; D006801:Humans; D058990:Molecular Targeted Therapy; D009362:Neoplasm Metastasis; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor
keywords: ESMO; clinical practice guidelines; colorectal cancer; consensus